Abstract
Pharmaceutical Nanotechnology can provide challenges for producing innovative drugs based on bio-inspired nanostructures (advanced Drug Delivery nano Systems—aDDnSs) [1]. These systems could be correlated to the living organisms due to their self-assembly properties, their hierarchical structural organization, as well as to their biocompatibility and biodegradability characteristics. aDDnSs can be considered as new therapeutic outcomes in nanomedicine that may be able to deliver pharmacomolecules to specific tissues and can improve their PK/PD (pharmacokinetics/pharmacodynamics) behavior and affect their total bioavailability. Drug delivery is a scientific sector that promotes the innovation by designing formulation approaches that can produce aDDnSs. Drug nanocarriers produced by the combination of bionanomaterials, such as liposomes, (co)polymers and dendrimers, are considered as new classes of complex self-assembled soft nanostructures.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
